Result
-€47,635 -€47,635
From profit to loss in 2022, after a profit of €275,021 in 2021.
DENTEPHARMA
Overview
Lifetime
8 annual accounts with figures on one time axispeak €675,969 (2016)
-€4,986▼ €295,828
lowest -€47,635 (2022)
-€47,635▼ €322,656
peak €2.0m (2020)
€1.9m▼ 2.4%
€526,839▼ 5.1%
Board3 names since 2021
1 directorDental Partners
Owners2 names in the annual accounts
100%Dental Partners and 1 other
Documentsfilings and deeds
28-08-202328 days late
2022abbreviated format
Gross margin from €290,842 to -€4,986Loss of €47,635Cash from €26,300 to €169
Key points
from the 2022 annual accounts, the last ones filedLiquidity
26.09 was 0.36 in 2021
Short-term debts fell from €511,934 to €4,603.
Filings
8 annual accounts 4 late
The 2021 accounts came latest: 61 days after the end of the period.
No score
Board and ownership
last known board- Dentcap consolidatesequity €14.4m (2025) · annual accounts 2022
Shares in 1 company, EUROPEAN ORAL IMPLANT CENTER
Board & ownershipRecent changes
Merger: absorbed by DENTIUS
Dissolution of the company · Dissolved without liquidation · Resignations: DENTAL PARTNERS (director) and Grant Thornton Bedrijfsrevisoren SCRL (statutory auditor) · General meeting of 31-07-2023 · Gazette deed
Merger: DENTEPHARMA takes over European Oral Implant Center
The company holds all the shares of European Oral Implant Center · General meeting of 31-07-2023 · Gazette deed
Merger proposal: to be absorbed by Dentius SRL
Permanent representatives: Bjorn Borghs and Bjom Borghs · Dental Partners SRL holds all the shares · Board meeting of 12-06-2023 · Gazette deed
Merger proposal: European Oral Implant Center SRL takes over European Oral Implant Center SRL
Gazette deed
Official details
Source: KBO- Status
- Absorbed by Dentius BVmerger by absorption, September 2023
- Activity
- “La prise de participation directe ou indirecte dans toutes sociétés ou entreprises commerciales,industrielles,financières,mobilières et…” (deed in French)From the articles, 14 activitiesNo NACE code in the KBO yet
- Financial year end
- 31 December
- Peppol
- Not found in the Peppol Directory
Insights on DENTEPHARMA
Absorbed by Dentius BV in September 2023. The last annual accounts are for financial year 2022. The company was dissolved without liquidation.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette.
Financials
Annual accounts 2022
abbreviated format, filed on 28-08-2023, 28 days late-€4,986
▼ €295,828
-€19,994
▼ €293,442
-€47,635
▼ €322,656
€115,466
▲ €445,523
78.5%
▲ 0.5 percentage points
26.09
▲ 25.73
Turnover: not included in this filing.
Balance sheet
balance sheet total €2.4m on 31-12-2022What the company ownsHow it is paid for
in €m
in euro
Filed annual accounts
as filed with the National Bank, click a year to choose it| Line | Trend | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|
| Balance sheet: assets | |||||||||
20/58 |
2.4m | 2.5m | 2.5m | 2.7m | 2.7m | 2.5m | 2.5m | 2.5m | |
21/28 |
2.3m | 2.3m | 2.4m | 2.4m | 2.4m | 2.3m | 2.3m | 2.3m | |
21 |
28,571 | 42,857 | 57,143 | 71,429 | 85,714 | - | - | - | |
22/27 |
- | - | - | 674 | 1,688 | 2,225 | - | - | |
23 |
- | - | - | - | 597 | 1,194 | - | - | |
24 |
- | - | - | 674 | 1,091 | 1,031 | - | - | |
28 |
2.3m | 2.3m | 2.3m | 2.3m | 2.3m | 2.3m | 2.3m | 2.3m | |
29/58 |
120,068 | 181,876 | 109,369 | 346,617 | 295,870 | 246,418 | 160,568 | 152,539 | |
29 |
- | - | - | - | - | - | 63,553 | 86,842 | |
291 |
- | - | - | - | - | - | 63,553 | 86,842 | |
40/41 |
119,899 | 155,505 | 93,215 | 320,175 | 266,063 | 223,075 | 67,937 | 17,381 | |
41 |
119,899 | 155,505 | 93,215 | 320,175 | 266,063 | 223,075 | 67,937 | 17,381 | |
54/58 |
169 | 26,300 | 15,613 | 25,112 | 26,900 | 8,341 | 29,077 | 48,317 | |
490/1 |
- | 71 | 542 | 1,330 | 2,907 | 15,002 | - | - | |
| Balance sheet: equity and liabilities | |||||||||
10/49 |
2.4m | 2.5m | 2.5m | 2.7m | 2.7m | 2.5m | 2.5m | 2.5m | |
10/15 |
1.9m | 2.0m | 2.0m | 1.7m | 1.7m | 1.2m | 904,484 | 508,019 | |
10/11 |
248,600 | 248,600 | 248,600 | 248,600 | 248,600 | 248,600 | 248,600 | 248,600 | |
10 |
248,600 | 248,600 | - | - | - | - | - | - | |
100 |
248,600 | 248,600 | 248,600 | 248,600 | 248,600 | 248,600 | 248,600 | 248,600 | |
13 |
1.7m | 1.7m | 1.7m | 1.5m | 1.4m | 983,860 | 654,860 | 254,860 | |
130/1 |
224,860 | 224,860 | 224,860 | 200,000 | 200,000 | 200,000 | - | - | |
130 |
24,860 | 24,860 | 24,860 | 24,860 | 24,860 | 24,860 | 24,860 | 24,860 | |
1319 |
200,000 | 200,000 | 200,000 | 200,000 | 200,000 | 200,000 | - | - | |
133 |
1.5m | 1.5m | 1.5m | 1.2m | 1.2m | 759,000 | 630,000 | 230,000 | |
14 |
-44,660 | 2,975 | 2,975 | 1,546 | 1,292 | 458 | 1,024 | 4,559 | |
17/49 |
526,839 | 555,299 | 497,077 | 1.0m | 1.0m | 1.3m | 1.6m | 1.9m | |
17 |
507,026 | 20,000 | 112,993 | 171,639 | 489,807 | 800,216 | 1.1m | 1.5m | |
170/4 |
507,026 | 20,000 | 112,993 | 171,639 | 489,807 | 800,216 | 1.1m | 1.5m | |
42/48 |
4,603 | 511,934 | 383,389 | 806,294 | 513,919 | 492,521 | 433,773 | 391,251 | |
42 |
- | 112,589 | 369,370 | 464,944 | 455,633 | 445,849 | 416,210 | 291,169 | |
43 |
- | 120,000 | - | - | - | - | - | - | |
439 |
- | 120,000 | - | - | - | - | - | - | |
44 |
4,603 | 4,298 | 3,442 | 3,396 | 3,294 | 2,558 | 363 | 2,261 | |
440/4 |
4,603 | 4,298 | 3,442 | 3,396 | 3,294 | 2,558 | 363 | 2,261 | |
45 |
- | - | 9,454 | 61,704 | 54,992 | 44,113 | 17,200 | 97,585 | |
450/3 |
- | - | 9,454 | 58,204 | 51,492 | 44,113 | 17,200 | 97,585 | |
454/9 |
- | - | - | 3,500 | 3,500 | - | - | - | |
47/48 |
- | 275,047 | 1,123 | 276,250 | - | - | - | 236 | |
492/3 |
15,211 | 23,365 | 695 | 22,780 | 23,795 | 22,989 | 23,004 | 22,929 | |
| Income statement | |||||||||
76A |
- | 16,774 | - | - | - | - | - | - | |
9900 |
-4,986 | 290,842 | 349,832 | 560,943 | 606,473 | 556,961 | 675,969 | 455,325 | |
630 |
14,286 | 14,286 | 14,960 | 16,648 | 16,338 | 1,295 | - | - | |
640/8 |
318 | 3,108 | 71 | 284 | 279 | 207 | 89 | - | |
66A |
404 | - | - | - | - | - | - | - | |
9901 |
-19,994 | 273,448 | 334,801 | 544,010 | 589,855 | 555,460 | 675,880 | 455,325 | |
75/76B |
- | 10,955 | 15,533 | 34,119 | 30,314 | 19,627 | 5,330 | 4,259 | |
75 |
- | 10,955 | 15,533 | 34,119 | 30,314 | 19,627 | 5,330 | 4,259 | |
65/66B |
17,707 | 9,382 | 14,410 | 21,421 | 29,956 | 42,539 | 80,533 | 66,572 | |
65 |
17,707 | 9,382 | 14,410 | 21,421 | 29,956 | 42,539 | 80,533 | 66,572 | |
9903 |
-37,702 | 275,021 | 335,923 | 556,708 | 590,213 | 532,547 | 600,676 | 393,012 | |
67/77 |
9,933 | - | 84,495 | 169,454 | 167,379 | 204,113 | 204,212 | 133,593 | |
9904 |
-47,635 | 275,021 | 251,428 | 387,254 | 422,834 | 328,434 | 396,464 | 259,419 | |
9905 |
-47,635 | 275,021 | 251,428 | 387,254 | 422,834 | 328,434 | 396,464 | 259,419 | |
| Appropriation of the result | |||||||||
9906 |
-44,660 | 277,996 | 252,975 | 388,546 | 423,292 | 329,458 | 401,024 | 259,419 | |
14P |
2,975 | 2,975 | - | - | - | - | - | - | |
691/2 |
- | - | 250,000 | 62,000 | 422,000 | 329,000 | 400,000 | 254,860 | |
6920 |
- | - | - | - | - | - | - | 24,860 | |
6921 |
- | - | 250,000 | 62,000 | 422,000 | 329,000 | 400,000 | 230,000 | |
694/7 |
- | 275,021 | - | 325,000 | - | - | - | - | |
694 |
- | - | - | 325,000 | - | - | - | - | |
695 |
- | 275,021 | - | - | - | - | - | - | |
| Document | |||||||||
The notes to these accounts have 12 items, including the statement of assets and debts, the cost breakdown and rights and commitments. You find them in the filed accounts (PDF).
Source: Annual accounts 2022 (PDF), filed on 28-08-2023.
Filings
each dot is a set of accounts, on the day it reached the National Bank2022 annual accounts filed 28 days after the deadline. Filed on 28 August 2023, deadline 31 July 2023 (7 months after the close on 31 December 2022, Companies Code art. 3:10). Source: NBB, 2023-00431415.
| Financial year | Type | Filed | Reference | Document |
|---|---|---|---|---|
| 31-12-2022 | abbreviated format | 28-08-2023 | 2023-00431415 | |
| 31-12-2021 | abbreviated format | 30-09-2022 | 2022-20452258 | |
| 31-12-2020 | full format | 25-06-2021 | 2021-25200202 | |
| 31-12-2019 | full format | 31-08-2020 | 2020-48600250 | |
| 31-12-2018 | full format | 26-08-2019 | 2019-53700276 | |
| 31-12-2017 | full format | 23-07-2018 | 2018-36600313 | |
| 31-12-2016 | full format | 30-06-2017 | 2017-25100518 | |
| 30-06-2015 | full format | 13-01-2016 | 2016-01900404 |
Key figures and ratios
per financial year, computed from the annual accounts| Line | Trend | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|
| -5,708 | 287,734 | 349,761 | 560,658 | 606,194 | 556,755 | - | - | ||
| -33,349 | 289,307 | 266,389 | 403,902 | 439,172 | 329,729 | - | - | ||
| 0 | 0 | 0 | 1,349 | 101,515 | 3,520 | - | 2.3m | ||
| -26,131 | 10,688 | -9,499 | -1,788 | 18,559 | -20,736 | -19,240 | - | ||
| 115,466 | -330,058 | -274,020 | -459,677 | -218,049 | -246,102 | -273,206 | -238,711 | ||
| 78.5% | 78.0% | 79.8% | 63.2% | 61.7% | 48.4% | 36.8% | 20.7% | ||
| 26.09 | 0.36 | 0.29 | 0.43 | 0.58 | 0.50 | 0.37 | 0.39 | ||
| 0.27 | 0.28 | 0.25 | 0.58 | 0.62 | 1.07 | 1.72 | 3.83 | ||
| -2.5% | 14.0% | 12.8% | 22.5% | 25.5% | 26.6% | 43.8% | 51.1% | ||
| -1.9% | 10.9% | 10.2% | 14.2% | 15.8% | 12.9% | 16.1% | 10.6% | ||
| -0.32 | 30.67 | - | - | - | - | - | - |
EBIT margin: not included in this filing.
A Belgian filing has no cash-flow statement. Cash flow is therefore an approximation, derived from the income statement. Investment is the acquisitions in the notes and, without them, the balance-sheet move.
Insights on DENTEPHARMA
The operating result for 2022 is a loss of €19,994, after a profit of €273,448 in 2021. It is the lowest result since 2015.
Debt's share of the balance-sheet total falls from 22.0% to 21.5%. Equity and debt are lower.
Board & ownership
Last board
1 auditor, last change in 2023Statutory auditor, permanent representative Nicolas Dumonceau
appointed by deed of 31-12-2021
Mandates through the years
3 names, the dashed line is todayGRANT THORNTON BEDRIJFSREVISOREN - REVISEURS D'ENTREPRISES
Statutory auditor
Statutory auditor
Dental Partners
Director
Director
MuhannadAlBunni
Director
Director
Earliermandate already running before its first mention
Mandates as a list
- GRANT THORNTON BEDRIJFSREVISOREN - REVISEURS D'ENTREPRISES
- Statutory auditor, appointed by deed of 31-12-2021, still in office
- Dental Partners
- Director, from 02-09-2021 to 30-08-2023
- MuhannadAlBunni
- Director, until 22-09-2021
Control
Consolidating parent
Equity €14.4m
Loss €9.3m in 2025 (loss €8.4m in 2024)
Source: parent in own accounts 2022
consolidates
This company
DENTEPHARMA
Equity €1.9m
Loss €47,635 in 2022
Capital
- Capital
- €248,600
- Shares
- 100
- Contribution per share
- €2,486
- Equity per share
- €19,218 in 2022
- Source
- deed of 22-06-2023
Owners through the years
as the annual accounts name themOwners as a list
- Dental Partners
- DENTCAP
Older annual accounts also name 1 natural person.
Source: shareholder structure in its own accounts, parent in its own accounts
Capital transactions
Shareholders according to the deeds
Stated in the deed
deed of 22-06-2023 ↗
- Dental Partners SRL (BE 0848.724.561) all shares
Capital over time
- 22-06-2023 Capital stated in the deed · €248,600 · 100 shares
Network & group
Holdings
own 2022 accountsThis companyDENTEPHARMA1 holding, 1 country
2022 accounts
Belgium 1 Equity Result
- BE European Oral Implant Center SPRLno longer active €70,973 result €25,159
Source: list of holdings in its own 2022 accounts. Every holding stands with its own latest accounts.
Parent
Dentcap
0678.614.968 · equity €14.4m · loss €9.3m (2025)
Earlier ties
| Dentius Administratiekantoor via Dental Partners, at DENTEPHARMA until 2023 · Director · deed of 02-01-2024 |
founded in 2023 |
| CABINET DENTAIRE DE MONS via Dental Partners, at DENTEPHARMA until 2023 · Director · deed of 27-02-2024 No longer active |
16 FTE (2023) |
| DENTIUS EKSEL via Dental Partners, at DENTEPHARMA until 2023 · Director · deed of 16-12-2022 No longer active |
3 FTE (2023) |
| INVIDENT via Dental Partners, at DENTEPHARMA until 2023 · Director · deed of 12-11-2019 No longer active |
4.9 FTE (2021) |
| CABINET DENTAIRE TEBACHE via Dental Partners, at DENTEPHARMA until 2023 · Sole director · deed of 12-08-2020 No longer active |
4.3 FTE (2019) |
| DILEO-DENT via Dental Partners, at DENTEPHARMA until 2023 · Director · deed of 28-09-2021 No longer active |
1.5 FTE (2022) |
Show 39 more earlier ties
| TANDARTSENPRAKTIJK VIJVERHOF via Dental Partners, at DENTEPHARMA until 2023 · Director · deed of 20-01-2023 No longer active |
5.2 FTE (2022) |
| KD DENTAL via Dental Partners, at DENTEPHARMA until 2023 · Director · deed of 04-02-2020 No longer active |
5.7 FTE (2023) |
| TAOPE NIHO via Dental Partners, at DENTEPHARMA until 2023 · Director · deed of 12-09-2019 No longer active |
4.6 FTE (2021) |
| Dentaz via Dental Partners, at DENTEPHARMA until 2023 · Director (not named in the articles) · deed of 09-02-2024 No longer active · founded in 2007 · group DENTCAP |
10 FTE (2025) |
| RENODENT via Dental Partners, at DENTEPHARMA until 2023 · Director · deed of 31-05-2023 No longer active |
6.8 FTE (2023) |
| SOFIE RUMMENS TANDARTSENPRAKTIJK via Dental Partners, at DENTEPHARMA until 2023 · Director · deed of 09-11-2020 No longer active |
3.5 FTE (2021) |
| OP DE BEECK - STORDEUR via Dental Partners, at DENTEPHARMA until 2023 · Director · deed of 03-02-2020 No longer active |
4.1 FTE (2022) |
| CABINET DENTAIRE ISTAT via Dental Partners, at DENTEPHARMA until 2023 · Director · deed of 15-07-2024 No longer active |
4.4 FTE (2024) |
| Dethodent via Dental Partners, at DENTEPHARMA until 2023 · Director · deed of 28-09-2021 No longer active |
0.8 FTE (2022) |
| TANDARTSPRAKTIJK E OOMEN BVBA via Dental Partners, at DENTEPHARMA until 2023 · Director · deed of 13-06-2024 No longer active |
2.1 FTE (2023) |
| TANDARTSENPRAKTIJK CALLEBAUT via Dental Partners, at DENTEPHARMA until 2023 · Director · deed of 12-02-2024 No longer active |
8.3 FTE (2023) |
| FRANK NAUDTS LTH via Dental Partners, at DENTEPHARMA until 2023 · Sole director · deed of 04-09-2020 No longer active |
2.7 FTE (2019) |
| DENTIUS ZELE via Dental Partners, at DENTEPHARMA until 2023 · Director · deed of 12-02-2024 No longer active |
3.6 FTE (2023) |
| QUADENT via Dental Partners, at DENTEPHARMA until 2023 · Director · deed of 03-03-2021 No longer active |
3.7 FTE (2021) |
| TANDARTS KATHLEEN DE BAERE via Dental Partners, at DENTEPHARMA until 2023 · Director · deed of 28-04-2022 No longer active |
2.5 FTE (2023) |
| Les Cabinets Dentaires Spécialisés E. LECOQ via Dental Partners, at DENTEPHARMA until 2023 · Director · deed of 19-05-2021 No longer active |
1.5 FTE (2021) |
| CLINIQUE DU FAUBOURG via Dental Partners, at DENTEPHARMA until 2023 · Sole director · deed of 12-08-2020 No longer active |
1.5 FTE (2020) |
| Tandartsenpraktijk Ledeberg via Dental Partners, at DENTEPHARMA until 2023 · Director · deed of 08-09-2020 No longer active |
2 FTE (2022) |
| HARELDENT via Dental Partners, at DENTEPHARMA until 2023 · Director · deed of 06-01-2020 No longer active |
3.8 FTE (2021) |
| PLAINE DENTAL via Dental Partners, at DENTEPHARMA until 2023 · Director · deed of 22-06-2020 No longer active |
2.8 FTE (2021) |
| DENTAL S-THETICS via Dental Partners, at DENTEPHARMA until 2023 · Director · deed of 11-02-2022 No longer active |
2 FTE (2023) |
| UCCLE DENTAL CENTER via Dental Partners, at DENTEPHARMA until 2023 · Director · deed of 08-09-2020 No longer active |
3 FTE (2021) |
| TANDARTSPRAKTIJK SPREUWERS via Dental Partners, at DENTEPHARMA until 2023 · Director · deed of 14-07-2023 No longer active |
2.7 FTE (2023) |
| H. VAN SANNEN via Dental Partners, at DENTEPHARMA until 2023 · Director · deed of 23-09-2021 No longer active |
1.6 FTE (2022) |
| MICHOLT INVEST via Dental Partners, at DENTEPHARMA until 2023 · Director · deed of 11-02-2022 No longer active |
total assets €449,055 (2022) |
| NADJMADENT via Dental Partners, at DENTEPHARMA until 2023 · Director · deed of 15-06-2020 No longer active |
2.7 FTE (2021) |
| DENTIUS FLEMALE via Dental Partners, at DENTEPHARMA until 2023 · Sole director · deed of 10-08-2020 No longer active |
2.9 FTE (2019) |
| DENTIUS HOESELT via Dental Partners, at DENTEPHARMA until 2023 · Director · deed of 10-07-2020 No longer active |
3.2 FTE (2021) |
| DENTAL CLINIC MICHOLT via Dental Partners, at DENTEPHARMA until 2023 · Managing director · deed of 15-05-2019 No longer active |
3 FTE (2022) |
| European oral care center via Dental Partners, at DENTEPHARMA until 2023 · Director · deed of 28-11-2024 No longer active · founded in 2018 · group DENTCAP |
3 FTE (2025) |
| CENTRE MEDICO-DENTAIRE DIGNEFFE EMILE via Dental Partners, at DENTEPHARMA until 2023 · Sole director · deed of 12-08-2020 No longer active |
2.7 FTE (2019) |
| OBJECTIF SOURIR ORTHO via Dental Partners, at DENTEPHARMA until 2023 · Director · deed of 07-04-2020 No longer active |
2.9 FTE (2021) |
| DE TANDENDOKTERS via Dental Partners, at DENTEPHARMA until 2023 · Sole director · deed of 09-09-2020 No longer active |
3.5 FTE (2019) |
| TANDARTSENPRAKTIJK DEINZE via Dental Partners, at DENTEPHARMA until 2023 · Sole director · deed of 05-08-2020 No longer active |
3.1 FTE (2019) |
| TANDARTSENPRAKTIJK GENT-WEST via Dental Partners, at DENTEPHARMA until 2023 · Sole director · deed of 05-08-2020 No longer active |
2.9 FTE (2019) |
| CABINET DE REHABILITATION DENTAIRE BONTEMPS-PETIT via Dental Partners, at DENTEPHARMA until 2023 · Sole director · deed of 10-08-2020 No longer active |
1.7 FTE (2019) |
| PAROIMPLANT via Dental Partners, at DENTEPHARMA until 2023 · Director · deed of 23-09-2019 No longer active |
2.4 FTE (2021) |
| CABINET DENTAIRE PHILIPPE LETIHON via Dental Partners, at DENTEPHARMA until 2023 · Director · deed of 25-11-2019 No longer active |
total assets €231,048 (2021) |
| DONTIA via Dental Partners, at DENTEPHARMA until 2023 · Sole director · deed of 09-09-2020 No longer active |
Holdings and subsidiaries
1 holdingHoldings 1
Share, source and own figures per holding (1)
- EUROPEAN ORAL IMPLANT CENTERsubsidiaryEquity €70,973 Profit of €25,159 in 2022100%
Holdings through the years 2015 to 2022
| Name | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|---|---|
| EUROPEAN ORAL IMPLANT CENTER | 100% | |||||||
Source: list of holdings in its own accounts
Acquisitions and mergers
2 transactionsTook over:EUROPEAN ORAL IMPLANT CENTER
Taken over by:Dentius BV
Connections & network
This company
Company
Director
Shareholding
+N: links not shown yet
Click a node to look further, drag to arrange, zoom with the mouse wheel.
Timeline
Timeline
21 events since 2014Board
Capital
Filings
Financial
End
Address
2014201620182020202220242026
2023
Merger: absorbed by DENTIUSDissolution of the company · Dissolved without liquidation · Resignations: DENTAL PARTNERS (director) and Grant Thornton Bedrijfsrevisoren SCRL (statutory auditor) · General meeting of 31-07-20235 points ▸
- General meeting, 31-07-2023
- Accounting effect, 01-01-2023
- Director resignation, DENTAL PARTNERS
- Permanent representative, BORGHS Bjorn
- Auditor resignation, Grant Thornton Bedrijfsrevisoren SCRL (statutory auditor)
- The deed holds 3 more points.
Annual accounts 2022 filed PDFabbreviated format · 28 days late
Merger: DENTEPHARMA takes over European Oral Implant CenterThe company holds all the shares of European Oral Implant Center · General meeting of 31-07-20234 points ▸
- The company holds all the shares of European Oral Implant Center
- Accounting effect, 01-01-2023
- Registered office clause, à 1000 Bruxelles, Boulevard Du Jardin Botanique 32, boîte 25
- General meeting, 31-07-2023
- The deed holds 4 more points.
Merger proposal: to be absorbed by Dentius SRLPermanent representatives: Bjorn Borghs and Bjom Borghs · Dental Partners SRL holds all the shares · Board meeting of 12-06-20237 points ▸
- Board meeting, 12-06-2023
- Permanent representative, Bjorn Borghs
- Permanent representative, Bjom Borghs (représentée en permanence)
- Dental Partners SRL holds all the shares, mentioned twice in the deed
- Capital, €248,600, 100 shares
- Capital, €5,528,394.94, 5,512 shares
- Accounting effect, 01-01-2023
- The deed holds 24 more points.
Merger proposal: European Oral Implant Center SRL takes over European Oral Implant Center SRL1 point ▸
- Accounting effect, 01-01-2023
- The deed holds 9 more points.
Registered office moved from Berchem-Sainte-Agathe to BrusselsNew registered office: Boulevard du jardin Botanique 32, boîte 25, 1000 Bruxelles · Previous registered office: Avenue Evariste De Meersman 35- 1082 Berchem-Sainte-Agathe · Board meeting of 20-04-20232 points ▸
- Board meeting, 20-04-2023
- Registered-office move, Boulevard du jardin Botanique 32, boîte 25, 1000 Bruxelles
Permanent representatives: Bjorn Borghs and Pieter LathouwersGeneral meeting of 20-12-20223 points ▸
- General meeting, 20-12-2022
- Permanent representative, Bjorn Borghs
- Permanent representative, Pieter Lathouwers
2022
Weakest financial year net -€47,635 The net result drops to -€47,635, the lowest from 2015 to 2022.
Liquidity more than 73 times current ratio 26.09 The current ratio rises from 0.36 to 26.09. Short-term debt falls from €511,934 to €4,603.
Annual accounts 2021 filed PDFabbreviated format · 61 days late
2021
Appointment: Grant Thornton Bedrijfsrevisoren SCRL (statutory auditor)General meeting of 21-12-20212 points ▸
- General meeting, 21-12-2021
- Auditor appointment, Grant Thornton Bedrijfsrevisoren SCRL (statutory auditor)
1 director appointed, 1 resignationResignation: MuhannadAlBunni · Appointment: DentalPartners · Permanent representative: PieterLathouwers · General meeting of 02-09-20214 points ▸
- General meeting, 02-09-2021
- Director resignation, MuhannadAlBunni
- Director appointment, DentalPartners
- Permanent representative, PieterLathouwers
Annual accounts 2020 filed PDFfull format · 36 days before the deadline
2020
Annual accounts 2019 filed PDFfull format · 31 days late
2019
Annual accounts 2018 filed PDFfull format · 26 days late
2018
Highest result from 2015 to 2022 net €422,834 ▲28.7% The net result of €422,834 is the highest of those years.
Annual accounts 2017 filed PDFfull format · 8 days before the deadline
2017
Equity above €1m equity €1.2m ▲36.3% With a profit in every financial year since 2015, equity grows to €1.2m.
Annual accounts 2016 filed PDFfull format · 31 days before the deadline
2016
Annual accounts 2015 filed PDFfull format · 18 days before the deadline
2014
Incorporation PDF11 publications in the Belgian Official Gazette, the last on 30-08-2023
Financial milestones sit on the financial year-end date, not the filing date.
Sources: Publications in the Belgian Official GazetteFilings with the National Bank
History
In 2023 the registered office moved to Brussels.1 EUROPEAN ORAL IMPLANT CENTER was merged into DENTEPHARMA in 2023.2 In 2023 the company was absorbed by merger into Dentius BV.3
Company details
Purpose according to the articles of association
- PurposeThe purpose describes the activities the company may carry out under its articles.
- “La prise de participation directe ou indirecte dans toutes sociétés ou entreprises commerciales,industrielles,financières,mobilières et…”
14 activities
- La prise de participation directe ou indirecte dans toutes sociétés ou entreprises commerciales,industrielles,financières,mobilières et immobilières;
- Le contrôle de leur gestion ou la participation à celle-ci par la prise de tous mandats au sein desdites sociétés ou entreprises;
- L'achat,l'administration,la vente de toutes valeurs mobilières et immobilières,de tous droits sociaux et d'une manière plus générale toutes opérations de gestion du portefeuille ainsi constitué.
- L'exploitation d'officine(s) de pharmacie,la fabrication et à la commercialisation de tous produits de pharmacie,de biothérapie,de diététique et de soins de beauté,le commerce de détail en accessoires,optique,parfumerie,et produits cosmétiques,l'achat et la vente de matières premières et l'exécution de toutes prescriptions médicales s'y rapportant,ainsi que le commerce de tous produits homéopathiques,vétérinaires,et de bandagisterie.
- Toutes activités de soins de dentisterie générale et notamment opératoire conformément aux règles déontologiques de la profession;la fabrication,la réparation et la pose de prothèse dentaire fixe,amovible ou sur implant;toutes activités d'endodontie,de pédodontie,de parodontologie,implantologie,orthodontie;orthopédie dentofaciale,occlusodontie,chirurgie orthognathique;toutes activités de chirurgie bucco-dentaire;
- La société a pour objet l'achat,l'échange,la vente,la prise en location et en sous location,ainsi que la cession en location et en sous location,le tout avec ou sans option d'achat,la gestion l'exploitation et l'entretien de tous biens immobiliers,fonds de commerce,terrains,terres et domaines,et de manière générale,et de tous droits réels,ainsi que toutes opérations de financement.
- La société pourra louer ou sous louer,acquérir des droits réels ou la pleine propriété de tout immeuble dans le but soit d'y établir son siège social,un siège d'exploitation ou d'y loger ses dirigeants et les membres de leur famille à titre de résidence principale.
- Au cas où la prestation de certains actes serait soumíse à des conditions préalables d'accès à la profession,la société subordonnera son action,en ce qui concerne ces prestations,à la réalisation de ces conditions.
- La société peut,d'une façon générale,accomplir toutes opérations commerciales,industrielles,financières,mobilières ou immobilières,se rapportant directement ou indirectement à son objet social ou qui seraient de nature à en faciliter directement ou indirectement,entièrement ou partiellement,la réalisation.
- Elle peut s'intéresser par voie d'apport,de fusion,de souscription ou de toute autre manière dans toutes affaires,entreprises associations ou sociétés ayant un objet identique,analogue ou connexe au sien,ou qui sont de nature à favoriser le développement de son entreprise,à lui procurer des matières premières ou à faciliter l'écoulement de ses produits.
- La société peut accepter et exercer un mandat d'administrateur,de gérant ou de liquidateur dans toutes sociétés,quel que soit son objet social.
- La société pourra exercer toutes activités d'intermédiaire commercial dans les domaines ci-dessus énumérés et dans tous secteurs dont l'activité n'est pas réglementée à ce jour.
- La société peut constituer hypothèque ou toute autre sûreté réelle sur les biens soclaux ou se porter caution.
- Elle peut prêter à toutes sociétés et/ou personnes physiques et se porter caution pour elles,même hypothécairement.
- Registered office clauseThe articles name the region of the registered office. The language of official documents depends on that region, among other things.
- “Boulevard du Jardin Botanique 32, boite 26, 1000 Bruxelles”
Articles of association, deed of 22-06-2023 (in French)
Inactive
Absorbed by Dentius BV in September 2023
DENTEPHARMA is no longer in the KBO register. Dentius BV took it over in a merger by absorption, published in the Belgian Official Gazette on 12 September 2023.
- Status
- Inactive
- Reason
- Merger by absorptionBelgian Official Gazette, 12 September 2023 · deed
- Absorbed by
- Dentius BV · 0521.880.388
- Last annual accounts
- financial year to 31 December 2022
- Last registered office
- Boulevard Du Jardin Botanique 32, Bte 25, 1000 Bruxellesas published on 30 August 2023
- Legal form
- Private limited company
- First annual accounts
- financial year 2015